Melanoma

>

Latest News

Lifileucel Approval Signals a Turning Point in Melanoma Therapy
Lifileucel Approval Signals a Turning Point in Melanoma Therapy

March 21st 2024

Lifileucel's FDA approval marks a breakthrough in melanoma treatment, offering hope with promising antitumor activity. While its potential extends to various solid tumors, challenges persist.

Lifileucel Shows Long-Term Efficacy in Melanoma
Lifileucel Shows Long-Term Efficacy in Melanoma

March 18th 2024

TILT-123/TIL Combo Appears Safe and Feasible in Metastatic Melanoma
TILT-123/TIL Combo Appears Safe and Feasible in Metastatic Melanoma

March 17th 2024

Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma
Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma

March 14th 2024

AHN Launches Cutting-Edge Melanoma and Skin Cancer Center
AHN Launches Cutting-Edge Melanoma and Skin Cancer Center

March 14th 2024

Video Series
Video Interviews
Podcasts

More News